Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Biopharmaceutical Excipients Market Research Report by Product, by Function, by Application, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
The Global Biopharmaceutical Excipients Market size was estimated at USD 188.70 million in 2020 and expected to reach USD 227.78 million in 2021, at a CAGR 21.04% to reach USD 593.66 million by 2026.
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2026 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Biopharmaceutical Excipients to forecast the revenues and analyze the trends in each of the following sub-markets:
- Based on Product, the market was studied across Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Specialty Excipients. The Carbohydrates is further studied across Dextrose, Starch, and Sucrose. The Polyols is further studied across Mannitol and Sorbitol. The Solubilizers & Surfactants/Emulsifiers is further studied across Esters and Triglycerides.
- Based on Function, the market was studied across Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers, and Preservatives.
- Based on Application, the market was studied across Advanced Delivery System, Oral, Parenteral, and Topical.
- Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biopharmaceutical Excipients Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Biopharmaceutical Excipients Market, including ABITEC Corporation, Ashland Inc., Associated British Foods PLC, BASF SE, Clariant AG, Colorcon, Inc., DFE Pharma, Dow Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD, Innophos Holdings Inc.,, J. RETTENMAIER & SOHNE GmbH + Co KG, JRS PHARMA, Meggle AG, Merck KGaA, Merck Millipore, Pharmonix Biological Pvt. Ltd, Roquette Freres, Sigachi Industries Pvt. Ltd., Spectrum Chemical Manufacturing Corp., SPI Pharma, The Lubrizol Corporation, and Wacker Chemie AG.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Biopharmaceutical Excipients Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biopharmaceutical Excipients Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biopharmaceutical Excipients Market?
4. What is the competitive strategic window for opportunities in the Global Biopharmaceutical Excipients Market?
5. What are the technology trends and regulatory frameworks in the Global Biopharmaceutical Excipients Market?
6. What is the market share of the leading vendors in the Global Biopharmaceutical Excipients Market?
7. What modes and strategic moves are considered suitable for entering the Global Biopharmaceutical Excipients Market?
Key Topics Covered:
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.2.1. Rising demand over better functionality and cutting-edge drug formulations
5.2.2. Rise in the need for large molecule development
5.2.3. Increasing development of Biosimilars
5.3. Restraints
5.3.1. High price of market product
5.4. Opportunities
5.4.1. Outsourcing of biologics manufacturing to emerge as a major trend
5.4.2. Substantial rise in need of functional excipients in recent years
5.5. Challenges
5.5.1. Formulation challenges for biopharmaceuticals development
6. Biopharmaceutical Excipients Market, by Product
6.1. Introduction
6.2. Carbohydrates
6.2.1. Dextrose
6.2.2. Starch
6.2.3. Sucrose
6.3. Polyols
6.3.1. Mannitol
6.3.2. Sorbitol
6.4. Solubilizers & Surfactants/Emulsifiers
6.4.1. Esters
6.4.2. Triglycerides
6.5. Specialty Excipients
7. Biopharmaceutical Excipients Market, by Function
7.1. Introduction
7.2. Binders
7.3. Coatings
7.4. Disintegrants
7.5. Lubricants & glidants
7.6. Pharmaceutical Fillers
7.7. Preservatives
8. Biopharmaceutical Excipients Market, by Application
8.1. Introduction
8.2. Advanced Delivery System
8.3. Oral
8.4. Parenteral
8.5. Topical
9. Americas Biopharmaceutical Excipients Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Biopharmaceutical Excipients Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Biopharmaceutical Excipients Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. ABITEC Corporation
13.2. Ashland Inc.
13.3. Associated British Foods PLC
13.4. BASF SE
13.5. Clariant AG
13.6. Colorcon, Inc.
13.7. DFE Pharma
13.8. Dow Chemical Company
13.9. Evonik Industries AG
13.10. Fuji Chemical Industries Co., Ltd.
13.11. IMCD
13.12. Innophos Holdings Inc.,
13.13. J. RETTENMAIER & SOHNE GmbH + Co KG
13.14. JRS PHARMA
13.15. Meggle AG
13.16. Merck KGaA
13.17. Merck Millipore
13.18. Pharmonix Biological Pvt. Ltd
13.19. Roquette Freres
13.20. Sigachi Industries Pvt. Ltd.
13.21. Spectrum Chemical Manufacturing Corp.
13.22. SPI Pharma
13.23. The Lubrizol Corporation
13.24. Wacker Chemie AG
14. Appendix
For more information about this report visit https://www.researchandmarkets.com/r/ln5d8i
